Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular biomolecule is a broad, collective term referring to any organic molecule located within the interior of a cell, including the cytoplasm, nucleus, and various organelles. This category encompasses a diverse range of chemical species such as proteins, nucleic acids (DNA and RNA), lipids, and carbohydrates, which are essential for maintaining cellular structure and executing biological processes (Alberts et al., 2002). Because this term describes a vast population of distinct molecules rather than a specific protein or gene, it is not considered a discrete therapeutic target in drug discovery. Instead, it serves as a general classification for the thousands of potential targets—such as enzymes, transcription factors, and structural proteins—that reside inside the cell (Cooper, 2000). Pharmacologically, drugs that interact with intracellular biomolecules must possess specific physicochemical properties, such as lipophilicity or the ability to utilize active transport, to cross the plasma membrane (Rang et al., 2019). Dysregulation of various intracellular biomolecules is central to the pathophysiology of numerous conditions, including oncogenesis, metabolic syndrome, and neurodegeneration. Due to the complexity and high concentration of these molecules within the cell, achieving high specificity and avoiding off-target toxicity remain significant challenges in developing therapies directed at intracellular components (NCBI, 2023).
Various mechanisms including enzyme inhibition, DNA intercalation, microtubule stabilization, and modulation of metabolic pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular biomolecule.